SARS-CoV-2 infection
Conditions
Interventions
None listed
Sponsors
Shionogi & Co., Ltd.
Osaka University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [Definition of COVID-19 patients and date of onset] -Patients with a diagnosis of COVID-19 [ICD-10 code (disease.icd10_sai_code): U071, U072 (no suspicionflag)] are considered as patients with COVID-19. -The smallest month of COVID-19 diagnosis (disease.shinryo_ym) from July 2019 to September 2022 is considered the first diagnosis month (IM: Index month). [Inclusion criteria of COVID-19 patients] -Observable from July 2019 to 6 months post-IM -IM is included from January 2020 to March 2022. [Definition of non-affected patients] -Patients without a diagnosis of COVID-19 [ICD-10 code (disease.icd10_sai_code): U071, U072, B342]. [Inclusion criteria of non-affected pathients] -Observable from July 2019 September 2022 [Creation of affected-unaffected pairs] -COVID-19-affected individuals who met the inclusion criteria are matched 1:1 with COVID-19-unaffected individuals who matched sex, date of birth, and risk factors for exacerbation.
Exclusion criteria
Exclusion criteria: In the population shown in the previous section, out of matched affected-unaffected pairs, if either pair had a diagnosis to be assessed during the 6 months prior to IM, that pair will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -The known long COVID Outcomes were defned by ICD10 codes related to diagnosis shown below. (cardiovascular disorders, arrhythmia, heart failure, acutemyocardial infarction, hypertension, asthma, respiratory failure, other respiratory diseases/symptoms, renal failure, chronickidney disease, blood coagulation/bleeding, thromboembolism, leukopenia, anemia, pulmonary thromboembolism, type I diabetes, type II diabetes, obesity, gastrointestinal/esophageal disorders, liver disease, smell/taste disorders, neurological conditions, cerebrovascular disorders, sleep disorders, other mental conditions, substance use disorders, anxiety, mood disorders, malaise , skeletal muscle pain, muscle disorder, hair loss, skin disease, atopic dermatitis, urticaria, herpes virus vesicular dermatitis, heart murmur, weight loss, ejaculation failure) For known long COVID, the outcome is not only each diagnosis, but also the entire known long COVID and the diagnosis grouped by each body system (cardiovascular system, respiratory system, kidney, coagulation/blood, endocrine system, digestive system, nervous system, mental system, muscular system, skin system, others). -The unknown long COVID ICD10 codes | — |
Countries
Japan
Contacts
Public ContactRyotaro Tajima
Shionogi & Co., Ltd. Data Science Department
Outcome results
None listed